Anti-tumor immune potentiation targets-engineered nanobiotechnologies: design principles and applications

R Jiao, X Lin, Q Zhang, Y Zhang, W Qin, Q Yang… - Progress in Materials …, 2024 - Elsevier
Combined therapeutic strategies hold promises in augmenting antigen release to enhance
anti-tumor immunity, which have garnered attention in numerous scholarly reviews. Beyond …

Emergence and impact of theranostic‐nanoformulation of triple therapeutics for combination cancer therapy

AK Rajora, ED Ahire, M Rajora, S Singh… - Smart …, 2024 - Wiley Online Library
Cancer remains a major global health threat necessitating the multipronged approaches for
its prevention and management. Traditional approaches in the form of chemotherapy …

Exploring the immunological profile in breast cancer: recent advances in diagnosis and prognosis through circulating tumor cells

A Kotsifaki, S Maroulaki, A Armakolas - International Journal of Molecular …, 2024 - mdpi.com
This review offers a comprehensive exploration of the intricate immunological landscape of
breast cancer (BC), focusing on recent advances in diagnosis and prognosis through the …

Bibliometric analysis of global research on tumor dormancy

Y Zhang, L Yan, Z Wang, F Li, J Lv, J Liu, X Liu, L Bao… - Cancers, 2023 - mdpi.com
Simple Summary Tumor dormancy continues to be a research hotspot with numerous
pressing problems that need to be solved. The goal of this study is to perform a bibliometric …

FBXW7 and human tumors: Mechanisms of drug resistance and potential therapeutic strategies

W Wang, K Jiang, X Liu, J Li, W Zhou… - Frontiers in …, 2023 - frontiersin.org
Drug therapy, including chemotherapy, targeted therapy, immunotherapy, and endocrine
therapy, stands as the foremost therapeutic approach for contemporary human …

SNAI2 enhances HPV‑negative cervical cancer cell dormancy by modulating u‑PAR expression and the activity of the ERK/p38 signaling pathway in vitro

Y Zhou, Y ** a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors
Y Dong, J Bai, J Zhou - Heliyon, 2024 - cell.com
Aims Cellular dormancy is a state of quiescence subpopulation of tumor cells, characterized
by low differentiation and lack of mitotic activity. They could evade chemotherapy and …

Matrix stiffness influences response to chemo and targeted therapy in brain metastatic breast cancer cells

V Yakati, LA Shevde, SS Rao - Biomaterials Science, 2024 - pubs.rsc.org
Breast cancer is the most common malignancy accounting for 12.5% of all newly diagnosed
cancer cases across the globe. Breast cancer cells are known to metastasize to distant …